Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

Detalles Bibliográficos
Autores principales: Corrigan, Margaret, Haydon, Geoffrey, Thompson, Fiona, Rajoriya, Neil, Peplow, Claire L, Hubscher, Stefan G, Steven, Neil, Hirschfield, Gideon M, Armstrong, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001532/
https://www.ncbi.nlm.nih.gov/pubmed/32039353
http://dx.doi.org/10.1016/j.jhepr.2019.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001532/
https://www.ncbi.nlm.nih.gov/pubmed/32039353
http://dx.doi.org/10.1016/j.jhepr.2019.02.001

Ejemplares similares